Objective Statins have been shown to be beneficial for the prevention of cardiovascular
events. In elderly individuals, the efficacy of statins remains controversial and the …

Statins are among the most widely prescribed medicines in the world and have proved their
value in reducing cardiovascular events and mortality. Many patients report adverse effects …

It has been clearly established that lipid-lowering treatments [such as 3-hydroxyl-3-
methylglutamyl coenzyme A reductase inhibitors ('statins') or fibrates] can reduce …

Statin monotherapy is generally well tolerated, with a low frequency of adverse events. The
most important adverse effects associated with statins are myopathy and an asymptomatic …

Elderly individuals are at higher risk for cardiovascular events, and thus this population
stands to gain a greater reduction in events from lipid therapy than younger individuals …

BACKGROUND:: Although statins have been demonstrated to be beneficial for secondary
prevention in the elderly, their use for primary prevention has not been well described …

Cholesterol-lowering drugs such as HMG-CoA reductase inhibitors (" statins") are
increasingly used in hypercholesterolemic patients who suffer from multiple concomitant …

Objective: The objective is to review the evidence evaluating the efficacy of statin therapy for
primary prevention of cardiovascular (CV) disease in the elderly. Data Sources: A literature …

Elderly patients commonly receive statin drugs for the primary or secondary prevention of
cardiovascular and cerebrovascular events. Elderly patients also commonly receive …

Atherosclerotic diseases are responsible for the majority of deaths in the elderly, and they
can also increase the risk of disability. Statins are first‐line therapies for lowering lipid levels …